GHRP-2 - Hubio Pharm

GHRP-2 emerged in the early 1990s as a second-generation growth hormone secretagogue. Synthesized by Dr. Bowers and his research team, it was developed to address the limitations of GHRP-6—particularly its strong appetite stimulation. GHRP-2 proved to be 2–3 times more potent in promoting GH release, with only moderate increases in cortisol and prolactin. The compound was eventually launched in Japan in 2005 and found broader application in clinical trials targeting short stature and GH deficiency. Despite limited FDA approval, it gained traction in research and hormone clinics worldwide​.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about GHRP-2 by Hubio Pharm, consult with your doctor or healthcare professional.